Senior Scientist I / II, tLNP Formulation

About AbbVie AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, oncology and neuroscience - and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at  www.abbvie.com . Follow @abbvie on  LinkedIn,   Facebook ,  Instagram ,  X  and  YouTube. About the Team The Targeted Lipid Nanoparticle (tLNP) drug product development group within AbbVie’s tLNP CMC team is committed to advancing clinical-stage tLNP assets from First-in-Human (FIH) through Phase 2. The team collaborates across biologics discovery, CMC partners, Clinical Operations, Regulatory Affairs, Quality Assurance, and external manufacturing to support development and commercialization of tLNP products. Key focus areas include establishing robust formulation and process development capabilities, leading critical CMC activities for pipeline programs, devising formulation development strategies, conducting stability evaluations, optimizing clinical in-use strategies, developing innovative product presentations, implementing stage-based quality risk management, and driving scientific initiatives to ensure the strong development of current and future tLNP programs. Purpose We are seeking a Senior Scientist I/II to lead key scientific initiatives and provide leadership in the development of early stage targeted Lipid Nanoparticle (tLNP) assets within AbbVie’s pipeline. This role is responsible for designing, executing, and effectively communicating hypothesis-driven formulation and process development activities. The successful candidate will collaborate closely with analytical teams, process development groups, and subject matter experts across AbbVie to advance research and development in the tLNP space. Responsibilities Develop risk-based drug product development strategies for clinical-stage tLNP programs Represent the tLNP formulation team in cross-functional forums, guiding program strategy and enabling key CMC deliverables and milestones, including IND- and BLA-enabling activities Assess tLNP liabilities under practical worst-case stress conditions to inform excipient selection and formulation screening strategies Design and execute comprehensive formulation screening studies, evaluating variables such as pH, buffer, antioxidants, surfactants, cryoprotectants, and other stabilizing excipients Lead process development, optimization, and robustness studies, with a focus on sterile fill-finish operations Facilitate scale-up, technology transfer, and manufacturing readiness in close collaboration with internal and external stakeholders Utilize statistical methods and Design of Experiments (DoE) to optimize formulations and process parameters Develop and communicate clinical in-use strategies for investigational products, including assessment of in-use stability for clinical-stage programs Plan and conduct experiments to evaluate innovative tLNP product presentations, such as lyophilized forms, spray-dried powders, nonaqueous suspensions, and other advanced formats Interpret and present critical data, key findings, and recommendations in both internal and cross-functional team forums Maintain high laboratory productivity while ensuring strict adherence to corporate safety, quality, and good research practices Practice robust documentation standards by accurately recording experimental data, results, and conclusions in electronic lab notebooks, technical reports, and scientific presentations Required PhD in Pharmaceutics, Pharmaceutical Sciences, Chemical Engineering, Biotechnology, or a related field (0+ years industry experience); or MS with 6+ years of relevant industry experience for senior scientist I PhD in Pharmaceutics, Pharmaceutical Sciences, Chemical Engineering, Biotechnology, or a related field (4+ years industry experience); or MS with 10+ years of relevant industry experience for senior scientist II Comprehensive theoretical knowledge of ICH regulations governing drug product formulation and sterile process development Proven experience in formulation, process development, and analytical characterization of protein therapeutics Experience characterizing thermal (glass transition, recrystallization) and physico-chemical (pH shifts) events taking place at sub-zero temperatures (typically -20°C to -80°C) in frozen drug product solutions Proficient in formulation characterization methods such as Dynamic Light Scattering (DLS), Differential Scanning Calorimetry (DSC), and chromatographic techniques (RP-HPLC, SEC, IEX) Demonstrated ability to independently design, execute, and troubleshoot complex formulation experiments Skilled at analyzing and interpreting multidisciplinary datasets to enable scientific decision-making Exceptional written and verbal scientific communication skills Preferred Hands-on experience in mRNA, lipid nanoparticles (LNP), targeted LNP systems, or biologics drug product development Demonstrated expertise in biologics manufacturing processes, including sterile fill-finish operations, lyophilization, and spray drying Strong familiarity with LNP and protein formulation characterization techniques such as mRNA encapsulation efficiency assays and antibody binding assays (qELISA) Proficient in utilizing statistical software and Design of Experiments (DoE) methodologies for process and formulation optimization. Applicable only to applicants applying to a position in any location with pay disclosure requirements under state or local law: ​ The compensation range described below is the range of possible base pay compensation that the Company believes in good faith it will pay for this role at the time of this posting based on the job grade for this position. Individual compensation paid